The latest edition of the HPRA newsletter includes important updates to support the safe and appropriate use of the following medicines:
- Montelukast: New boxed warning to raise further awareness of the risk of neuropsychiatric events
- Paracetamol: Monitoring risk factors for hepatotoxicity in patients during treatment
- Ustekinumab: New warning regarding lupus-related conditions and updated advice regarding infections
- Venlafaxine: Updated warning and advice on complex cases involving overdose and severe poisoning